Liminatus Pharma, Inc. - 8-K Filing

Liminatus Pharma appoints Eric Sunghee Kang as Chief Corporate Strategist effective November 16, 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $LIMN

Read the full article at SEC EDGAR

More Regulatory news